Literature DB >> 22508411

Increase of meningococcal serogroup Y cases in Europe: a reason for concern?

Michael Bröker1, Susanne Jacobsson, Lisa DeTora, David Pace, Muhamed-Kheir Taha.   

Abstract

Neisseria meningitidis is differentiated into 12 distinct serogroups of which A, B, C, W-135, X and Y are medically most important and represent a major health problem in one or more parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. A sudden increase or decrease of IMD or meningococcal carriage may occur anywhere at any time. Recent epidemiological surveillance indicates an increase of serogroup Y IMD in some parts of Europe and data from various European countries are presented.

Entities:  

Mesh：

Year:  2012        PMID： 22508411     DOI： 10.4161/hv.20098

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  9 in total

1.  Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

Authors:  Michael Bröker; Suzana Bukovski; Davor Culic; Susanne Jacobsson; Maria Koliou; Markku Kuusi; Maria João Simões; Anna Skoczynska; Maija Toropainen; Muhamed-Keir Taha; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

Review 2.  Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).

Authors:  Jamie D Croxtall; Sohita Dhillon
Journal:  Drugs       Date:  2012-12-24       Impact factor: 9.546

3.  Meningococcal serogroup Y emergence in Europe: update 2011.

Authors:  Michael Bröker; Susanne Jacobsson; Markku Kuusi; David Pace; Maria J Simões; Anna Skoczynska; Muhamed-Kheir Taha; Maija Toropainen; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

4.  Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.

Authors:  Josefien Cornelie Minthe Bousema; Joost Ruitenberg
Journal:  Int J Health Policy Manag       Date:  2015-09-13

5.  Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012.

Authors:  Bianca Törös; Sara T Hedberg; Magnus Unemo; Susanne Jacobsson; Dorothea M C Hill; Per Olcén; Hans Fredlund; Holly B Bratcher; Keith A Jolley; Martin C J Maiden; Paula Mölling
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

6.  Genomic analysis of Neisseria meningitidis carriage isolates during an outbreak of serogroup C clonal complex 11, Tuscany, Italy.

Authors:  Luigina Ambrosio; Arianna Neri; Cecilia Fazio; Gian Maria Rossolini; Paola Vacca; Eleonora Riccobono; Fabio Voller; Alessandro Miglietta; Paola Stefanelli
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

7.  Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.

Authors:  R Abad; E L López; R Debbag; J A Vázquez
Journal:  Epidemiol Infect       Date:  2014-05-15       Impact factor: 4.434

Review 8.  New versus old meningococcal group B vaccines: how the new ones may benefit infants & toddlers.

Authors:  D Panatto; D Amicizia; P L Lai; M L Cristina; A Domnich; R Gasparini
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

Review 9.  A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.

Authors:  Yih-Ling Tzeng; David S Stephens
Journal:  Microorganisms       Date:  2021-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.